한글목차

세계의 체외진단용 라텍스 입자 시장 규모는 2024년 5,102만 달러에서 2030년에는 7,025만 달러로 성장하며, 예측 기간 중 연간 평균 성장률(CAGR)은 5.48%에 달할 것으로 예측됩니다.

현재 체외진단 업계용 라텍스 입자의 시장 집중도는 높은 기술 장벽으로 인해 비교적 높습니다. 주요 참여 기업은 JSR Life Sciences, Merck, Bangs Laboratories, Thermo Fisher, VDO Biotech 등입니다. JSR Life Sciences는 최대기업으로, 2023년의 세계 매출 점유율은 47.55%입니다.

제품 유형별로 시장의 주류는 카르복시 변성 라텍스 입자로, 시장 점유율의 60% 이상을 차지하고 있습니다. 제품 용도로서는 라텍스 면역비탁측정이 최대 용도 방향이며, 50% 이상을 차지하고 있습니다.

소비에 관해서는 북미, 중국, 유럽이 주요 소비 지역으로, 2023년 세계 총매출의 93.27%를 누적으로 차지하고 있습니다.

세계의 체외진단용 라텍스 입자 시장에 대해 조사했으며, 시장의 개요와 유형별, 용도별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.

목차

제1장 조사 대상 범위

• 체외진단용 라텍스 입자 제품 소개
• 유형별 시장
• 용도별 시장
• 전제와 제한
• 조사 목적
• 대상년

제2장 세계의 체외진단용 라텍스 입자 생산

• 세계의 체외진단용 라텍스 입자 생산능력(2019-2030년)
• 세계의 체외진단용 라텍스 입자 생산량 : 2019년 대 2023년 대 2030년, 지역별
• 세계의 체외진단용 라텍스 입자 생산량, 지역별
• 미국
• 유럽
• 중국
• 일본

제3장 개요

제4장 제조업체 간 경쟁

제5장 시장 규모(유형별)

• 세계의 체외진단용 라텍스 입자 판매(유형별)
• 세계의 체외진단용 라텍스 입자 매출(유형별)
• 세계의 체외진단용 라텍스 입자 가격(유형별)

제6장 시장 규모(용도별)

• 세계의 체외진단용 라텍스 입자 판매(용도별)
• 세계의 체외진단용 라텍스 입자 매출(용도별)
• 세계의 체외진단용 라텍스 입자 가격(용도별)

제7장 미국·캐나다

제8장 유럽

제9장 중국

제10장 아시아(중국 제외)

제11장 중동 및 아프리카, 라틴아메리카

제12장 기업 개요

• JSR Life Sciences
• Merck
• Bangs Laboratories
• Thermo Fisher
• Agilent
• IKERLAT Polymers
• Fujikura Kasei
• CD Bioparticles
• VDO Biotech
• Suzhou NanoMicro
• Sunresin New Materials

제13장 산업 체인과 판매채널 분석

• 체외진단용 라텍스 입자 산업 체인 분석
• 체외진단용 라텍스 입자의 주요 원재료
• 체외진단용 라텍스 입자의 제조 모드와 프로세스
• 체외진단용 라텍스 입자 판매 및 마케팅
• 체외진단용 라텍스 입자

제14장 체외진단용 라텍스 입자 시장 역학

제15장 체외진단용 라텍스 입자에 관한 세계 규모 조사의 주요 조사 결과

제16장 부록

영문목차

The global Latex Particle for In-Vitro Diagnostics market is projected to grow from US$ 51.02 million in 2024 to US$ 70.25 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.48% during the forecast period.

At present, the market concentration of the latex particle for IVD industry is relatively high due to the high technology barrier. Key players include JSR Life Sciences, Merck, Bangs Laboratories, Thermo Fisher, VDO Biotech and so on. JSR Life Sciences is the largest player, accounting for 47.55% revenue share globally in 2023.

In terms of product types, the mainstream product on the market is carboxy-modified latex particles, which occupies more than 60% of the market share. As for product applications, latex immunoturbidimetry is the largest application direction, accounting for more than 50%.

For consumption, North America, China and Europe are the main consumption areas, cumulatively accounting for 93.27% of the global total sales in 2023.

In terms of production side, this report researches the Latex Particle for In-Vitro Diagnostics production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

In terms of consumption side, this report focuses on the sales of Latex Particle for In-Vitro Diagnostics by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.

Report Includes:

This report presents an overview of global market for Latex Particle for In-Vitro Diagnostics, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Latex Particle for In-Vitro Diagnostics, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Latex Particle for In-Vitro Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Latex Particle for In-Vitro Diagnostics sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Latex Particle for In-Vitro Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Latex Particle for In-Vitro Diagnostics sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including JSR Life Sciences, Merck, Bangs Laboratories, Thermo Fisher, Agilent, IKERLAT Polymers, Fujikura Kasei, CD Bioparticles, and VDO Biotech, etc.

Market Segmentation

By Company

• JSR Life Sciences
• Merck
• Bangs Laboratories
• Thermo Fisher
• Agilent
• IKERLAT Polymers
• Fujikura Kasei
• CD Bioparticles
• VDO Biotech
• Suzhou NanoMicro
• Sunresin New Materials

Segment by Type

• Plain Latex Particles
• Carboxy-Modified Latex Particles
• Other

Segment by Application

• Latex Immunoturbidimetry
• Latex Agglutination Test
• Immunochromatography
• Other

Production by Region

• North America
• Europe
• China
• Japan

Sales by Region

US & Canada

• U.S.
• Canada

China

Asia (excluding China)

• Japan
• South Korea
• China Taiwan
• Southeast Asia
• India Europe
• Germany
• France
• U.K.
• Italy
• Russia

Middle East, Africa, Latin America

• Brazil
• Mexico
• Turkey
• GCC Countries

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Latex Particle for In-Vitro Diagnostics production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 3: Sales (consumption), revenue of Latex Particle for In-Vitro Diagnostics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Latex Particle for In-Vitro Diagnostics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 9: China by Type, and by Application, sales, and revenue for each segment.

Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Latex Particle for In-Vitro Diagnostics sales, revenue, price, gross margin, and recent development, etc.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 15: The main points and conclusions of the report.

Table of Contents

1 Study Coverage

• 1.1 Latex Particle for In-Vitro Diagnostics Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Latex Particle for In-Vitro Diagnostics Market Size by Type, 2019 VS 2023 VS 2030
  • 1.2.2 Plain Latex Particles
  • 1.2.3 Carboxy-Modified Latex Particles
  • 1.2.4 Other
• 1.3 Market by Application
  • 1.3.1 Global Latex Particle for In-Vitro Diagnostics Market Size by Application, 2019 VS 2023 VS 2030
  • 1.3.2 Latex Immunoturbidimetry
  • 1.3.3 Latex Agglutination Test
  • 1.3.4 Immunochromatography
  • 1.3.5 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Latex Particle for In-Vitro Diagnostics Production

• 2.1 Global Latex Particle for In-Vitro Diagnostics Production Capacity (2019-2030)
• 2.2 Global Latex Particle for In-Vitro Diagnostics Production by Region: 2019 VS 2023 VS 2030
• 2.3 Global Latex Particle for In-Vitro Diagnostics Production by Region
  • 2.3.1 Global Latex Particle for In-Vitro Diagnostics Historic Production by Region (2019-2024)
  • 2.3.2 Global Latex Particle for In-Vitro Diagnostics Forecasted Production by Region (2025-2030)
  • 2.3.3 Global Latex Particle for In-Vitro Diagnostics Production Market Share by Region (2019-2030)
• 2.4 USA
• 2.5 Europe
• 2.6 China
• 2.7 Japan

3 Executive Summary

• 3.1 Global Latex Particle for In-Vitro Diagnostics Revenue Estimates and Forecasts 2019-2030
• 3.2 Global Latex Particle for In-Vitro Diagnostics Revenue by Region
  • 3.2.1 Global Latex Particle for In-Vitro Diagnostics Revenue by Region: 2019 VS 2023 VS 2030
  • 3.2.2 Global Latex Particle for In-Vitro Diagnostics Revenue by Region (2019-2024)
  • 3.2.3 Global Latex Particle for In-Vitro Diagnostics Revenue by Region (2025-2030)
  • 3.2.4 Global Latex Particle for In-Vitro Diagnostics Revenue Market Share by Region (2019-2030)
• 3.3 Global Latex Particle for In-Vitro Diagnostics Sales Estimates and Forecasts 2019-2030
• 3.4 Global Latex Particle for In-Vitro Diagnostics Sales by Region
  • 3.4.1 Global Latex Particle for In-Vitro Diagnostics Sales by Region: 2019 VS 2023 VS 2030
  • 3.4.2 Global Latex Particle for In-Vitro Diagnostics Sales by Region (2019-2024)
  • 3.4.3 Global Latex Particle for In-Vitro Diagnostics Sales by Region (2025-2030)
  • 3.4.4 Global Latex Particle for In-Vitro Diagnostics Sales Market Share by Region (2019-2030)
• 3.5 US & Canada
• 3.6 Europe
• 3.7 China
• 3.8 Asia (excluding China)
• 3.9 Middle East, Africa and Latin America

4 Competition by Manufacturers

• 4.1 Global Latex Particle for In-Vitro Diagnostics Sales by Manufacturers
  • 4.1.1 Global Latex Particle for In-Vitro Diagnostics Sales by Manufacturers (2019-2024)
  • 4.1.2 Global Latex Particle for In-Vitro Diagnostics Sales Market Share by Manufacturers (2019-2024)
  • 4.1.3 Global Top 3 and Top 5 Largest Manufacturers of Latex Particle for In-Vitro Diagnostics in 2023
• 4.2 Global Latex Particle for In-Vitro Diagnostics Revenue by Manufacturers
  • 4.2.1 Global Latex Particle for In-Vitro Diagnostics Revenue by Manufacturers (2019-2024)
  • 4.2.2 Global Latex Particle for In-Vitro Diagnostics Revenue Market Share by Manufacturers (2019-2024)
  • 4.2.3 Global Top 3 and Top 5 Companies by Latex Particle for In-Vitro Diagnostics Revenue in 2023
• 4.3 Global Latex Particle for In-Vitro Diagnostics Sales Price by Manufacturers (2019-2024)
• 4.4 Global Key Players of Latex Particle for In-Vitro Diagnostics, Industry Ranking, 2022 VS 2023
• 4.5 Analysis of Competitive Landscape
  • 4.5.1 Manufacturers Market Concentration Ratio (CR5)
  • 4.5.2 Global Latex Particle for In-Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.6 Global Key Manufacturers of Latex Particle for In-Vitro Diagnostics, Manufacturing Base Distribution and Headquarters
• 4.7 Global Key Manufacturers of Latex Particle for In-Vitro Diagnostics, Product Offered and Application
• 4.8 Establish Date of Global Key Manufacturers of Latex Particle for In-Vitro Diagnostics
• 4.9 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type

• 5.1 Global Latex Particle for In-Vitro Diagnostics Sales by Type
  • 5.1.1 Global Latex Particle for In-Vitro Diagnostics Historical Sales by Type (2019-2024)
  • 5.1.2 Global Latex Particle for In-Vitro Diagnostics Forecasted Sales by Type (2025-2030)
  • 5.1.3 Global Latex Particle for In-Vitro Diagnostics Sales Market Share by Type (2019-2030)
• 5.2 Global Latex Particle for In-Vitro Diagnostics Revenue by Type
  • 5.2.1 Global Latex Particle for In-Vitro Diagnostics Historical Revenue by Type (2019-2024)
  • 5.2.2 Global Latex Particle for In-Vitro Diagnostics Forecasted Revenue by Type (2025-2030)
  • 5.2.3 Global Latex Particle for In-Vitro Diagnostics Revenue Market Share by Type (2019-2030)
• 5.3 Global Latex Particle for In-Vitro Diagnostics Price by Type
  • 5.3.1 Global Latex Particle for In-Vitro Diagnostics Price by Type (2019-2024)
  • 5.3.2 Global Latex Particle for In-Vitro Diagnostics Price Forecast by Type (2025-2030)

6 Market Size by Application

• 6.1 Global Latex Particle for In-Vitro Diagnostics Sales by Application
  • 6.1.1 Global Latex Particle for In-Vitro Diagnostics Historical Sales by Application (2019-2024)
  • 6.1.2 Global Latex Particle for In-Vitro Diagnostics Forecasted Sales by Application (2025-2030)
  • 6.1.3 Global Latex Particle for In-Vitro Diagnostics Sales Market Share by Application (2019-2030)
• 6.2 Global Latex Particle for In-Vitro Diagnostics Revenue by Application
  • 6.2.1 Global Latex Particle for In-Vitro Diagnostics Historical Revenue by Application (2019-2024)
  • 6.2.2 Global Latex Particle for In-Vitro Diagnostics Forecasted Revenue by Application (2025-2030)
  • 6.2.3 Global Latex Particle for In-Vitro Diagnostics Revenue Market Share by Application (2019-2030)
• 6.3 Global Latex Particle for In-Vitro Diagnostics Price by Application
  • 6.3.1 Global Latex Particle for In-Vitro Diagnostics Price by Application (2019-2024)
  • 6.3.2 Global Latex Particle for In-Vitro Diagnostics Price Forecast by Application (2025-2030)

7 US & Canada

• 7.1 US & Canada Latex Particle for In-Vitro Diagnostics Market Size by Type
  • 7.1.1 US & Canada Latex Particle for In-Vitro Diagnostics Sales by Type (2019-2030)
  • 7.1.2 US & Canada Latex Particle for In-Vitro Diagnostics Revenue by Type (2019-2030)
• 7.2 US & Canada Latex Particle for In-Vitro Diagnostics Market Size by Application
  • 7.2.1 US & Canada Latex Particle for In-Vitro Diagnostics Sales by Application (2019-2030)
  • 7.2.2 US & Canada Latex Particle for In-Vitro Diagnostics Revenue by Application (2019-2030)
• 7.3 US & Canada Latex Particle for In-Vitro Diagnostics Market Size by Country
  • 7.3.1 US & Canada Latex Particle for In-Vitro Diagnostics Revenue by Country: 2019 VS 2023 VS 2030
  • 7.3.2 US & Canada Latex Particle for In-Vitro Diagnostics Revenue by Country (2019-2030)
  • 7.3.3 US & Canada Latex Particle for In-Vitro Diagnostics Sales by Country (2019-2030)
  • 7.3.4 US
  • 7.3.5 Canada

8 Europe

• 8.1 Europe Latex Particle for In-Vitro Diagnostics Market Size by Type
  • 8.1.1 Europe Latex Particle for In-Vitro Diagnostics Sales by Type (2019-2030)
  • 8.1.2 Europe Latex Particle for In-Vitro Diagnostics Revenue by Type (2019-2030)
• 8.2 Europe Latex Particle for In-Vitro Diagnostics Market Size by Application
  • 8.2.1 Europe Latex Particle for In-Vitro Diagnostics Sales by Application (2019-2030)
  • 8.2.2 Europe Latex Particle for In-Vitro Diagnostics Revenue by Application (2019-2030)
• 8.3 Europe Latex Particle for In-Vitro Diagnostics Market Size by Country
  • 8.3.1 Europe Latex Particle for In-Vitro Diagnostics Revenue by Country: 2019 VS 2023 VS 2030
  • 8.3.2 Europe Latex Particle for In-Vitro Diagnostics Sales by Country (2019-2030)
  • 8.3.3 Europe Latex Particle for In-Vitro Diagnostics Revenue by Country (2019-2030)
  • 8.3.4 Germany
  • 8.3.5 France
  • 8.3.6 U.K.
  • 8.3.7 Italy
  • 8.3.8 Russia

9 China

• 9.1 China Latex Particle for In-Vitro Diagnostics Market Size by Type
  • 9.1.1 China Latex Particle for In-Vitro Diagnostics Sales by Type (2019-2030)
  • 9.1.2 China Latex Particle for In-Vitro Diagnostics Revenue by Type (2019-2030)
• 9.2 China Latex Particle for In-Vitro Diagnostics Market Size by Application
  • 9.2.1 China Latex Particle for In-Vitro Diagnostics Sales by Application (2019-2030)
  • 9.2.2 China Latex Particle for In-Vitro Diagnostics Revenue by Application (2019-2030)

10 Asia (excluding China)

• 10.1 Asia Latex Particle for In-Vitro Diagnostics Market Size by Type
  • 10.1.1 Asia Latex Particle for In-Vitro Diagnostics Sales by Type (2019-2030)
  • 10.1.2 Asia Latex Particle for In-Vitro Diagnostics Revenue by Type (2019-2030)
• 10.2 Asia Latex Particle for In-Vitro Diagnostics Market Size by Application
  • 10.2.1 Asia Latex Particle for In-Vitro Diagnostics Sales by Application (2019-2030)
  • 10.2.2 Asia Latex Particle for In-Vitro Diagnostics Revenue by Application (2019-2030)
• 10.3 Asia Latex Particle for In-Vitro Diagnostics Market Size by Region
  • 10.3.1 Asia Latex Particle for In-Vitro Diagnostics Revenue by Region: 2019 VS 2023 VS 2030
  • 10.3.2 Asia Latex Particle for In-Vitro Diagnostics Revenue by Region (2019-2030)
  • 10.3.3 Asia Latex Particle for In-Vitro Diagnostics Sales by Region (2019-2030)
  • 10.3.4 Japan
  • 10.3.5 South Korea
  • 10.3.6 China Taiwan
  • 10.3.7 Southeast Asia
  • 10.3.8 India

11 Middle East, Africa and Latin America

• 11.1 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Market Size by Type
  • 11.1.1 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Sales by Type (2019-2030)
  • 11.1.2 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Revenue by Type (2019-2030)
• 11.2 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Market Size by Application
  • 11.2.1 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Sales by Application (2019-2030)
  • 11.2.2 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Revenue by Application (2019-2030)
• 11.3 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Market Size by Country
  • 11.3.1 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Revenue by Country: 2019 VS 2023 VS 2030
  • 11.3.2 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Revenue by Country (2019-2030)
  • 11.3.3 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Sales by Country (2019-2030)
  • 11.3.4 Brazil
  • 11.3.5 Mexico
  • 11.3.6 Turkey
  • 11.3.7 GCC Countries

12 Corporate Profile

• 12.1 JSR Life Sciences
  • 12.1.1 JSR Life Sciences Corporation Information
  • 12.1.2 JSR Life Sciences Overview
  • 12.1.3 JSR Life Sciences Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
  • 12.1.4 JSR Life Sciences Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.1.5 JSR Life Sciences Recent Developments
• 12.2 Merck
  • 12.2.1 Merck Company Information
  • 12.2.2 Merck Overview
  • 12.2.3 Merck Latex Particle for In-Vitro Diagnostics Sales, Price, Revenue and Gross Margin (2019-2024)
  • 12.2.4 Merck Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.2.5 Merck Recent Developments
• 12.3 Bangs Laboratories
  • 12.3.1 Bangs Laboratories Corporation Information
  • 12.3.2 Bangs Laboratories Overview
  • 12.3.3 Bangs Laboratories Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
  • 12.3.4 Bangs Laboratories Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.3.5 Bangs Laboratories Recent Developments
• 12.4 Thermo Fisher
  • 12.4.1 Thermo Fisher Corporation Information
  • 12.4.2 Thermo Fisher Overview
  • 12.4.3 Thermo Fisher Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
  • 12.4.4 Thermo Fisher Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.4.5 Thermo Fisher Recent Developments
• 12.5 Agilent
  • 12.5.1 Agilent Corporation Information
  • 12.5.2 Agilent Overview
  • 12.5.3 Agilent Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
  • 12.5.4 Agilent Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.5.5 Agilent Recent Developments
• 12.6 IKERLAT Polymers
  • 12.6.1 IKERLAT Polymers Corporation Information
  • 12.6.2 IKERLAT Polymers Overview
  • 12.6.3 IKERLAT Polymers Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
  • 12.6.4 IKERLAT Polymers Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.6.5 IKERLAT Polymers Recent Developments
• 12.7 Fujikura Kasei
  • 12.7.1 Fujikura Kasei Corporation Information
  • 12.7.2 Fujikura Kasei Overview
  • 12.7.3 Fujikura Kasei Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
  • 12.7.4 Fujikura Kasei Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
• 12.8 CD Bioparticles
  • 12.8.1 CD Bioparticles Corporation Information
  • 12.8.2 CD Bioparticles Overview
  • 12.8.3 CD Bioparticles Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
  • 12.8.4 CD Bioparticles Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.8.5 CD Bioparticles Recent Developments
• 12.9 VDO Biotech
  • 12.9.1 VDO Biotech Corporation Information
  • 12.9.2 VDO Biotech Overview
  • 12.9.3 VDO Biotech Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
  • 12.9.4 VDO Biotech Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.9.5 VDO Biotech Recent Developments
• 12.10 Suzhou NanoMicro
  • 12.10.1 Suzhou NanoMicro Corporation Information
  • 12.10.2 Suzhou NanoMicro Overview
  • 12.10.3 Suzhou NanoMicro Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
  • 12.10.4 Suzhou NanoMicro Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.10.5 Suzhou NanoMicro Recent Developments
• 12.11 Sunresin New Materials
  • 12.11.1 Sunresin New Materials Corporation Information
  • 12.11.2 Sunresin New Materials Overview
  • 12.11.3 Sunresin New Materials Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
  • 12.11.4 Sunresin New Materials Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications

13 Industry Chain and Sales Channels Analysis

• 13.1 Latex Particle for In-Vitro Diagnostics Industry Chain Analysis
• 13.2 Latex Particle for In-Vitro Diagnostics Key Raw Materials
  • 13.2.1 Key Raw Materials
  • 13.2.2 Raw Materials Key Suppliers
• 13.3 Latex Particle for In-Vitro Diagnostics Production Mode & Process
• 13.4 Latex Particle for In-Vitro Diagnostics Sales and Marketing
  • 13.4.1 Latex Particle for In-Vitro Diagnostics Sales Channels
  • 13.4.2 Latex Particle for In-Vitro Diagnostics Distributors
• 13.5 Latex Particle for In-Vitro Diagnostics Customers

14 Latex Particle for In-Vitro Diagnostics Market Dynamics

• 14.1.1 Latex Particle for In-Vitro Diagnostics Industry Trends
• 14.1.2 Latex Particle for In-Vitro Diagnostics Market Drivers
• 14.1.3 Latex Particle for In-Vitro Diagnostics Market Challenges
• 14.1.4 Latex Particle for In-Vitro Diagnostics Market Restraints

15 Key Findings in the Global Latex Particle for In-Vitro Diagnostics Study

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details 195